- Home
- SEDG vs ADPT Comparison
SEDG vs ADPT Comparison
Compare SEDG & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEDG
- ADPT
- Stock Information
- Founded
- SEDG 2006
- ADPT 2009
- Country
- SEDG Israel
- ADPT United States
- Employees
- SEDG N/A
- ADPT N/A
- Industry
- SEDG Semiconductors
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SEDG Technology
- ADPT Health Care
- Exchange
- SEDG Nasdaq
- ADPT Nasdaq
- Market Cap
- SEDG 976.4M
- ADPT 1.1B
- IPO Year
- SEDG 2015
- ADPT 2019
- Fundamental
- Price
- SEDG $12.64
- ADPT $7.33
- Analyst Decision
- SEDG Hold
- ADPT Strong Buy
- Analyst Count
- SEDG 26
- ADPT 5
- Target Price
- SEDG $26.33
- ADPT $9.40
- AVG Volume (30 Days)
- SEDG 3.3M
- ADPT 2.4M
- Earning Date
- SEDG 05-07-2025
- ADPT 05-01-2025
- Dividend Yield
- SEDG N/A
- ADPT N/A
- EPS Growth
- SEDG N/A
- ADPT N/A
- EPS
- SEDG N/A
- ADPT N/A
- Revenue
- SEDG $901,456,000.00
- ADPT $178,957,000.00
- Revenue This Year
- SEDG $22.02
- ADPT $21.20
- Revenue Next Year
- SEDG $34.73
- ADPT $22.06
- P/E Ratio
- SEDG N/A
- ADPT N/A
- Revenue Growth
- SEDG N/A
- ADPT 5.10
- 52 Week Low
- SEDG $10.24
- ADPT $2.28
- 52 Week High
- SEDG $64.04
- ADPT $9.01
- Technical
- Relative Strength Index (RSI)
- SEDG 41.21
- ADPT 43.95
- Support Level
- SEDG $12.03
- ADPT $7.38
- Resistance Level
- SEDG $14.18
- ADPT $8.30
- Average True Range (ATR)
- SEDG 1.63
- ADPT 0.75
- MACD
- SEDG -0.25
- ADPT -0.04
- Stochastic Oscillator
- SEDG 27.02
- ADPT 33.85
About SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).